September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Cryopreserved Amniotic Membrane After Epithelial Debridement for Recurrent Corneal Erosion
Author Affiliations & Notes
  • Scott G Hauswirth
    Ophthalmology & Medicine, Minnesota Eye Consultants PA, Blaine, Minnesota, United States
  • Milton M Hom
    Private Practice, Azusa, California, United States
  • Footnotes
    Commercial Relationships   Scott Hauswirth, Allergan (C), Bausch+Lomb (C), BioTissue (C), Shire (C), TearScience (C); Milton Hom, Allergan (F), AMO (F), Bausch+Lomb (F), OptoVue (R), Shire (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4356. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Scott G Hauswirth, Milton M Hom; Cryopreserved Amniotic Membrane After Epithelial Debridement for Recurrent Corneal Erosion. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4356.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Recurrent corneal erosion is a common condition in clinical practice. Cryopreserved amnion tissue (CAM) is increasingly used in clinical ophthalmic practice for a variety of conditions. At present, no comparative studies examining outcomes for treatment of recurrent corneal erosion (RCE) utilizing bandage contact lens (BCL) versus CAM exist. This case series attempts to examine whether the recurrence rate of RCE treated by bandage contact lens alone (BCLA), epithelial debridement plus BCL (ED+BCL), or epithelial debridement plus CAM (ED+CAM) differs.

Methods : 44 eyes of 44 patients treated for RCE at a single site were retrospectively reviewed. Patients with less than 3 months follow up or who received treatment methods other than those studied were excluded. Outcomes were examined between BCLA group (n=5, males=3, mean age=51.6 years), ED+BCL group (n=5, males=1, mean age=48.2) and ED+CAM group (n=6, males=0, average age=60.33 years) for incidence of recurrence (defined as patient description of an incident of pain, or visible epithelial slough on examination), and post-treatment haze.

Results : In the BCLA group, average follow up period was 37.6mo (range 8–84mo). Recurrence occurred in 4 patients (80%). Average time to recurrence was 2.44mo (range 0.25-8mo). In the ED+BCL group, average follow up period was 41.2mo (range 34-50mo). Recurrence occurred in 2 patients (40%), with average time of 11.25mo (range 0.5-22mo). In the ED+CAM group, average follow-up period was 7.5mo (range 3–13mo). Although the follow up period in the ED+CAM was shorter, no recurrence occurred, and was comparable to mean time of recurrence across all groups (5.375mo). Corneal haze was noted in one patient in the ED+BCL group (20%) and one patient in the ED+CAM group (16.6%).

Conclusions : Compared to bandage contact lens alone, ED+BCL and ED+CAM reduced rate of recurrence. No patients in the ED+CAM group experienced signs or symptoms of recurrent erosion during their follow up period. Based on our results, addition of cryopreserved amniotic membrane to epithelial debridement enhanced treatment and reduced recurrence of RCE. Incidence of haze was similar between ED+BCL and ED+CAM groups. Further studies using larger numbers of patients are warranted.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.